| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A cross-species translational pharmacokinetic-pharmacodynamic evaluation of core body temperature reduction by the TRPM8 blocker PF-05105679
|
Gosset, James R.
|
|
2017
|
109 |
S |
p. S161-S167
7 p.
|
artikel
|
| 2 |
A human challenge model for respiratory syncytial virus kinetics, the pharmacological effect of a novel fusion inhibitor, and the modelling of symptoms scores
|
Korell, Julia
|
|
2017
|
109 |
S |
p. S154-S160
7 p.
|
artikel
|
| 3 |
Allometric size: The scientific theory and extension to normal fat mass
|
Holford, Nick H.G.
|
|
2017
|
109 |
S |
p. S59-S64
6 p.
|
artikel
|
| 4 |
Assessment of translational risk in drug research: Role of biomarker classification and mechanism-based PKPD concepts
|
Visser, Sandra A.G.
|
|
2017
|
109 |
S |
p. S72-S77
6 p.
|
artikel
|
| 5 |
Biomarkers in epilepsy–A modelling perspective
|
van Dijkman, Sven C.
|
|
2017
|
109 |
S |
p. S47-S52
6 p.
|
artikel
|
| 6 |
Calendar of Events
|
|
|
2017
|
109 |
S |
p. I-
1 p.
|
artikel
|
| 7 |
Combined proportional and additive residual error models in population pharmacokinetic modelling
|
Proost, Johannes H.
|
|
2017
|
109 |
S |
p. S78-S82
5 p.
|
artikel
|
| 8 |
Diurnal variation in the pharmacokinetics and brain distribution of morphine and its major metabolite
|
Kervezee, Laura
|
|
2017
|
109 |
S |
p. S132-S139
8 p.
|
artikel
|
| 9 |
Drug-disease modeling in the pharmaceutical industry - where mechanistic systems pharmacology and statistical pharmacometrics meet
|
Helmlinger, Gabriel
|
|
2017
|
109 |
S |
p. S39-S46
8 p.
|
artikel
|
| 10 |
Drugs in space: Pharmacokinetics and pharmacodynamics in astronauts
|
Kast, Johannes
|
|
2017
|
109 |
S |
p. S2-S8
7 p.
|
artikel
|
| 11 |
Editorial board members
|
|
|
2017
|
109 |
S |
p. IFC-
1 p.
|
artikel
|
| 12 |
Editorial Special Supplement of the European Journal of Pharmaceutical Sciences on the occasion of the retirement of Professor Meindert Danhof as Professor of Pharmacology at Leiden University
|
Burggraaf, Koos
|
|
2017
|
109 |
S |
p. S1-
1 p.
|
artikel
|
| 13 |
Evidence-based drug treatment for special patient populations through model-based approaches
|
Krekels, Elke H.J.
|
|
2017
|
109 |
S |
p. S22-S26
5 p.
|
artikel
|
| 14 |
Exposure–response relationship of regorafenib efficacy in patients with hepatocellular carcinoma
|
Solms, Alexander
|
|
2017
|
109 |
S |
p. S149-S153
5 p.
|
artikel
|
| 15 |
Genotype-guided dosing of warfarin through modeling and simulation
|
Deng, Jiexin
|
|
2017
|
109 |
S |
p. S9-S14
6 p.
|
artikel
|
| 16 |
Impact of pharmacokinetic-pharmacodynamic modelling in early clinical drug development
|
Dingemanse, Jasper
|
|
2017
|
109 |
S |
p. S53-S58
6 p.
|
artikel
|
| 17 |
Integrating clinical metabolomics-based biomarker discovery and clinical pharmacology to enable precision medicine
|
Kohler, Isabelle
|
|
2017
|
109 |
S |
p. S15-S21
7 p.
|
artikel
|
| 18 |
Model-based clinical dose optimization for phenobarbital in neonates: An illustration of the importance of data sharing and external validation
|
Völler, Swantje
|
|
2017
|
109 |
S |
p. S90-S97
8 p.
|
artikel
|
| 19 |
Model-based precision dosing of sirolimus in pediatric patients with vascular anomalies
|
Mizuno, Tomoyuki
|
|
2017
|
109 |
S |
p. S124-S131
8 p.
|
artikel
|
| 20 |
Non-maturational covariates for dynamic systems pharmacology models in neonates, infants, and children: Filling the gaps beyond developmental pharmacology
|
Allegaert, Karel
|
|
2017
|
109 |
S |
p. S27-S31
5 p.
|
artikel
|
| 21 |
Open innovation: Towards sharing of data, models and workflows
|
Conrado, Daniela J.
|
|
2017
|
109 |
S |
p. S65-S71
7 p.
|
artikel
|
| 22 |
Population pharmacokinetics of carvedilol enantiomers and their metabolites in healthy subjects and type-2 diabetes patients
|
Nardotto, Glauco H.B.
|
|
2017
|
109 |
S |
p. S108-S115
8 p.
|
artikel
|
| 23 |
Population pharmacokinetics of NNZ-2566 in healthy subjects
|
Oosterholt, Sean P.
|
|
2017
|
109 |
S |
p. S98-S107
10 p.
|
artikel
|
| 24 |
Population pharmacokinetics of oxcarbazepine and its metabolite 10-hydroxycarbazepine in healthy subjects
|
Antunes, Natalicia de Jesus
|
|
2017
|
109 |
S |
p. S116-S123
8 p.
|
artikel
|
| 25 |
The influence of drug distribution and drug-target binding on target occupancy: The rate-limiting step approximation
|
de Witte, W.E.A.
|
|
2017
|
109 |
S |
p. S83-S89
7 p.
|
artikel
|
| 26 |
Towards personalized treatment of pain using a quantitative systems pharmacology approach
|
Goulooze, Sebastiaan C.
|
|
2017
|
109 |
S |
p. S32-S38
7 p.
|
artikel
|
| 27 |
Use of mathematics to guide target selection in systems pharmacology; application to receptor tyrosine kinase (RTK) pathways
|
Benson, Neil
|
|
2017
|
109 |
S |
p. S140-S148
9 p.
|
artikel
|
Tijdschrift beschrijving